CRC

我们是谁

  • 1 月 5, 2024
    Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
  • 4 月 5, 2022
    HLX208（BRAF V600E 抑制剂）联合西妥昔单抗治疗一线治疗后出现 BRAF V600E 突变的转移性结直肠癌 (mCRC) 的疗效观察

发现舞蹈艺术

发现舞蹈艺术

无论您喜欢芭蕾、爵士还是街舞，我们都有适合您的课程。